Mfd. by :- Aprazer healthcare (Fulfilled By : Magicine Pharma)
Magicine Pharma is registered with the Government Of NCT, India, Ministry Of Health in Government of Delhi, India, registration number DL-RAJ-122372 and as a wholesale distributor, department file No. 44208.
Brand name: Imatikast
Generic name: Imatinib
Dosage form: Tablet
Indication: Blood Cancer
Storage: Store at room temperature
Imatikast contains Imatinib and it is recommended for the treatment of Blood cancer (Chronic myeloid leukemia and Acute lymphocytic leukemia). This cancer-fighting medication belongs to a class of drugs known as tyrosine kinase inhibitors. Imatikast is available in the form of a tablet with a strength of 400mg. Take this medication orally with food as prescribed by your GP (general practitioner).
Imatinib is a 2-phenylaminopyrimidine derivative and antineoplastic drug used to treat chronic myelogenous leukemia. It inhibits a number of tyrosine kinase enzymes in a specific manner. Chronic myelogenous leukemia is linked to the Philadelphia chromosome, which promotes the BCR-ABL mutation, which is caused by the fusion of two genes, BCR and ABL. BCR-ABL generates a fusion protein that acts as a constitutively active tyrosine kinase and imatinib works to inhibit this constitutive enzymatic activity.
Imatikast tablet is prescribed by your healthcare professional for use in the treatment of Blood cancer and GIST (gastrointestinal stromal tumor). To take most of the benefit, administer this medication at the same time each day. Do not take Imatikast tablets in the wrong way and the duration of the treatment depends on the response of the patient's body. For better efficacy complete the dosing schedule as per your healthcare expert guidelines.
It is important to know the interactions of Imatikast tablets with other drugs and diseases, before starting therapy with this medicinal formulation.
Bone marrow suppression
Avoid consuming alcohol while receiving treatment with Imatikast tablet.
Imatikast tablet is not indicated for use in the below-mentioned cases. Do not use this medication if any of the below-mentioned apply to you:-
Hypersensitive to the active ingredients present in the medication.
Allergic to Imatinib.
Severe or moderate side effects may occur during treatment with Imatikast tablets, if side effects last longer than usual inform your healthcare practitioner as soon as possible.
Loss of appetite
Altered sense of taste
Heartburn and indigestion
Burning or tingling sensation of skin
Difficulty in falling asleep
Swelling of the hands, feet, ankle, and lower legs
Severe breathing difficulty
Presence of blood in cough
Yellowing of skin and eyes
Note:- It is advisable to contact a healthcare expert if side effects occur.
Take Imatikast tablet as prescribed by your medical professional. Make sure to take this anti-cancer formulation in the same amount as directed by your physician.
If you miss a scheduled dose of Imatikast tablet, contact your GP immediately to know the ways of coping with the missed or skipped dose.
In case of an overdose, the patient is advised to consult a healthcare practitioner as soon as possible if any unusual symptoms occur.
Inform your GP (general practitioner) if you have any pre-existing disorder. Check all the possible benefits and risks before starting treatment with Imatikast tablet.
Imatikast (Imatinib) tablets are not recommended for use in pregnant women because it may affect the unborn baby.
Do not use Imatikast (Imatinib) tablet in breastfeeding. Talk to your healthcare provider before starting treatment with Imatikast.
Before starting treatment with Imatikast (Imatinib) tablet, inform your GP (general practitioner) if you are suffering from a Hepatic disorder.
If you are allergic to any of the active ingredients present in the Imatikast tablet.
Do not start your therapy, if you have a pre-existing disorder of congestive heart failure.
Make sure to disclose your previous and current clinical condition in order to avoid interactions.
The use of Imatikast (Imatinib) tablet may cause some severe allergic reactions.
Do not drive or operate heavy machinery
Do not skip a dose
Do not overdose
Do not increase or decrease the dose strength of the Imatikast (Imatinib) tablet
Do not break or chew the Imatikast tablet
Q1- What is Imatikast?
Ans- Imatikast contains Imatinib and it is recommended for the treatment of Blood cancer (Chronic myeloid leukemia and Acute lymphocytic leukemia).
Q2- What are the side effects of Imatikast?
Ans- Common side effects of Imatikast tablet are:- diarrhea, nausea, unusual bleeding, abdominal pain, bloating, bloody stool, vomiting, mouth sores, loss of appetite, altered sense of taste, etc.
Q3- What happens if I miss a dose of Imatikast?
Ans- If you miss a scheduled dose of Imatikast tablet, contact your GP immediately to know the ways of coping with the missed or skipped dose.
Q4- What happens if I overdose on Imatikast?
Ans- In case of an overdose, the patient is advised to consult a healthcare practitioner as soon as possible if any unusual symptoms occur.
Q5- Is Imatikast safe for use in pregnant women?
Ans- Imatikast tablets are not recommended for use in pregnant women because it may cause harm to the fetus.
Q6- Is Imatikast safe for use in nursing women?
Ans- The use of Imatikast (Imatinib) tablets is not safe in breastfeeding.
Q7- What is the available strength of Imatikast?
Ans- Imatikast (Imatinib) is available in the strength of 400mg.
Q8- How is Imatikast administered?
Ans- Administer the Imatikast tablet orally as recommended by the general practitioner and follow your regular dosing schedule.
Q9- Can I drive after taking Imatikast?
Ans- It is not advisable to drive after taking Imatikast because it can cause side effects like blurred vision and dizziness.
Q10- Is alcohol consumption safe during Imatikast therapy?
Ans- Consult it with your health practitioner, before starting treatment with Imatikast tablet.